세계의 바이러스 벡터 정제 시장 보고서(2025년)
Viral Vector Purification Global Market Report 2025
상품코드 : 1889612
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,505,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,403,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,301,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

바이러스 벡터 정제 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 14억 8,000만 달러로 평가되었고, 2025년에는 17억 5,000만 달러에 달할 것으로 추정되며, CAGR 18.3%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 바이오 의약품 생산 능력의 확대, 조사에서 바이러스 벡터의 이용 증가, 바이오 기술 사업에 대한 정부 자금 증가, 수탁 제조 기관(CMO)의 성장 및 학계와 산업계의 협력 강화와 관련이 있습니다.

바이러스 벡터 정제 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 33억 8,000만 달러에 달할 것으로 예측되며, CAGR 17.9%로 성장할 전망입니다. 예측 기간의 성장요인으로는 정교한 기술에 대한 투자 증가, 확장 가능한 제조 솔루션에 대한 주목 증가, 유전자 전달 플랫폼의 지속적인 확대, 신흥 시장에서 바이러스 벡터의 보급 확대, 효율적인 다운스트림 공정 처리에 대한 수요 증가 등이 있습니다. 예측 기간 동안 예상되는 주요 동향으로는 새로운 정제 기술 개발, 단일 청소년 바이오프로세스 시스템 혁신, 연속 정제 워크플로우 진보, 하이브리드 크로마토그래피 기술의 출현, 자동화 프로세스 모니터링 기술의 발전 등이 예상됩니다.

유전자 치료에 대한 수요 증가는 향후 수년간 바이러스 벡터 정제 시장의 성장을 이끌 것으로 예측됩니다. 유전자 치료란 질병의 치료 및 예방을 목적으로 환자의 세포 내에 유전 물질을 도입, 제거, 개변하는 의료 기술입니다. 유전자 치료 수요 증가는 유전 물질을 세포 내로 안전하고 효율적이며 표적 지향적으로 도입할 수 있는 전달 시스템의 진보에 의해 촉진되고 있습니다. 바이러스 벡터 정제는 바이러스 벡터가 고품질, 안전하고 생물학적으로 활성임을 보장함으로써 유전자 치료를 향상시키는 데 중요한 역할을 합니다. 불순물을 제거하고 벡터의 성능을 최적화함으로써 치료 효과를 높여 신뢰성이 높고 효율적인 치료 결과를 가져옵니다. 예를 들어, 2024년 12월 미국 비영리 의료 과학 단체인 미국 유전자 및 세포 치료 학회(ASGCT)는 식품의약국(FDA)이 2023년 6건의 유전자 치료 제품을 승인했다고 보고했습니다. 이것은 2022년 5건에서 증가한 수치입니다. 이와 같이 유전자 치료에 대한 수요 증가가 바이러스 벡터 정제 시장의 성장을 가속하고 있습니다.

바이러스 벡터 정제 시장의 주요 기업은 매크로 질량 광도 측정 플랫폼과 같은 신속하고 높은 처리량 분석 솔루션에 주력하고 있습니다. 이러한 플랫폼은 광산란을 이용하여 바이러스 입자의 크기와 질량을 측정하여 빈 캡시드와 충진 캡시드의 정확한 식별과 분해 입자의 검출을 몇 분 이내에 가능하게 합니다. 예를 들어, 2023년 11월에는 영국 생명 공학 회사인 Refeyn Ltd.가 아데노바이러스 및 렌티바이러스 벡터를 단 6분 내에 분석할 수 있는 매크로 질량 광도 측정 플랫폼인 KaritroMP를 발표했습니다. 본 플랫폼은 최대 13 검체의 반자동 처리를 실현하고 품질 관리에 높은 재현성을 제공함과 동시에 미세한 입자 질량의 변동을 검출함으로써 정제 공정의 최적화를 가능하게 합니다. 이 제품의 출시는 바이러스 벡터 제조업체의 능력을 강화하고 벡터 품질을 보다 빠르고 정확한 평가를 가능하게 합니다. 동시에, 워크플로우의 효율화를 도모하고, 벡터의 특성 평가 및 정제에 필요한 시간 및 자원의 삭감을 실현합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Viral vector purification is the procedure of separating viral vectors from production-related impurities, including host cell proteins, DNA, and other contaminants, to obtain a highly pure and safe final product. Its main goal is to ensure that viral vectors are appropriate for therapeutic use, maintaining their effectiveness and safety in gene therapy applications.

The primary vector types involved in viral vector purification include adenoviral vectors, lentiviral vectors, adeno-associated viral vectors, retroviral vectors, and others. Adenoviral vectors are viruses engineered to deliver genetic material into cells and are widely used in gene therapy and vaccine development. The process encompasses product types such as kits, reagents, instruments, and services, employing purification methods like chromatography, ultrafiltration, precipitation, and more. These techniques support applications in gene therapy, vaccinology, research, and other fields, serving end users including pharmaceutical and biotechnology companies, academic and research institutions, contract research organizations, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The viral vector purification market research report is one of a series of new reports from The Business Research Company that provides viral vector purification market statistics, including the viral vector purification industry global market size, regional shares, competitors with the viral vector purification market share, detailed viral vector purification market segments, market trends, and opportunities, and any further data you may need to thrive in the viral vector purification industry. This viral vector purification market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The viral vector purification market size has grown rapidly in recent years. It will grow from $1.48 billion in 2024 to $1.75 billion in 2025 at a compound annual growth rate (CAGR) of 18.3%. Growth during the historic period can be linked to expanding biopharmaceutical production capacity, increased use of viral vectors in research, rising government funding for biotechnology initiatives, the growth of contract manufacturing organizations, and strengthening collaborations between academia and industry.

The viral vector purification market size is expected to see rapid growth in the next few years. It will grow to $3.38 billion in 2029 at a compound annual growth rate (CAGR) of 17.9%. Growth in the forecast period can be attributed to rising investment in advanced purification technologies, a heightened focus on scalable manufacturing solutions, continued expansion of gene delivery platforms, broader adoption of viral vectors in emerging markets, and growing demand for efficient downstream processing. Key trends anticipated in the forecast period include the development of new purification methods, innovations in single-use bioprocessing systems, advancements in continuous purification workflows, the emergence of hybrid chromatography approaches, and progress in automated process monitoring technologies.

The growing demand for gene therapies is expected to drive the expansion of the viral vector purification market in the coming years. Gene therapies are medical treatments that involve the introduction, removal, or modification of genetic material within a patient's cells to treat or prevent diseases. The increasing demand for gene therapies is fueled by advancements in delivery systems that enable the safe, efficient, and targeted delivery of genetic material into cells. Viral vector purification plays a vital role in enhancing gene therapies by ensuring that viral vectors are of high quality, safe, and biologically active. It improves the effectiveness of therapies by removing impurities and optimizing vector performance, leading to reliable and efficient treatment outcomes. For example, in December 2024, the American Society of Gene & Cell Therapy (ASGCT), a U.S.-based non-profit medical and scientific organization, reported that the Food and Drug Administration (FDA) approved six gene therapy products in 2023, up from five approvals in 2022. As such, the increasing demand for gene therapies is fueling the growth of the viral vector purification market.

Key players in the viral vector purification market are focusing on rapid, high-throughput analytical solutions, such as macro mass photometry platforms. These platforms use light scattering to measure the size and mass of viral particles, allowing for precise differentiation between empty and full capsids and detection of degraded particles within minutes. For example, in November 2023, Refeyn Ltd., a UK-based biotechnology company, launched KaritroMP, a macro mass photometry platform designed to analyze adenovirus and lentivirus vectors in just six minutes. This platform offers semi-automated sample processing for up to 13 samples, provides high reproducibility for quality control, and can detect subtle variations in particle mass to optimize purification processes. The launch enhances the capabilities of viral vector manufacturers by enabling faster and more accurate assessment of vector quality, while also streamlining workflow efficiency and reducing time and resources spent on vector characterization and purification.

In September 2025, Thermo Fisher Scientific Inc., a U.S.-based scientific instruments and life sciences company, acquired Solventum's purification and filtration business for approximately $4.0 billion. With this acquisition, Thermo Fisher strengthens its bioprocessing portfolio by integrating Solventum's advanced purification and filtration technologies, which will enhance the quality, efficiency, and end-to-end capabilities of viral vector manufacturing workflows, both upstream and downstream. Solventum Corporation, a U.S.-based healthcare company, specializes in bioprocessing filtration and purification solutions, including products that support viral vector purification.

Major companies operating in the viral vector purification market are Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, FUJIFILM Diosynth Biotechnologies, Danaher Corporation, Sartorius AG, Agilent Technologies Inc., Eurofins Scientific SE, Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., AGC Biologics A/S, CoJourney, Takara Bio Inc., Miltenyi Biotec B.V. & Co. KG, Oxford Biomedica PLC, Revvity Inc., Applied Biological Materials Inc. (ABM), Minapharm Pharmaceuticals, Batavia Biosciences B.V., Creative Biolabs Inc., Andelyn Biosciences Inc.

North America was the largest region in the viral vector purification market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in viral vector purification report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the viral vector purification market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The viral vector purification market includes revenues earned by entities through process development, analytical testing, formulation development, chromatography, ultrafiltration, precipitation, quality control, viral clearance validation, scale-up optimization, and stability testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Viral Vector Purification Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on viral vector purification market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for viral vector purification ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral vector purification market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Viral Vector Purification Market Characteristics

3. Viral Vector Purification Market Trends And Strategies

4. Viral Vector Purification Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Viral Vector Purification Growth Analysis And Strategic Analysis Framework

6. Viral Vector Purification Market Segmentation

7. Viral Vector Purification Market Regional And Country Analysis

8. Asia-Pacific Viral Vector Purification Market

9. China Viral Vector Purification Market

10. India Viral Vector Purification Market

11. Japan Viral Vector Purification Market

12. Australia Viral Vector Purification Market

13. Indonesia Viral Vector Purification Market

14. South Korea Viral Vector Purification Market

15. Western Europe Viral Vector Purification Market

16. UK Viral Vector Purification Market

17. Germany Viral Vector Purification Market

18. France Viral Vector Purification Market

19. Italy Viral Vector Purification Market

20. Spain Viral Vector Purification Market

21. Eastern Europe Viral Vector Purification Market

22. Russia Viral Vector Purification Market

23. North America Viral Vector Purification Market

24. USA Viral Vector Purification Market

25. Canada Viral Vector Purification Market

26. South America Viral Vector Purification Market

27. Brazil Viral Vector Purification Market

28. Middle East Viral Vector Purification Market

29. Africa Viral Vector Purification Market

30. Viral Vector Purification Market Competitive Landscape And Company Profiles

31. Viral Vector Purification Market Other Major And Innovative Companies

32. Global Viral Vector Purification Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Viral Vector Purification Market

34. Recent Developments In The Viral Vector Purification Market

35. Viral Vector Purification Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기